Načítá se...
A Newborn with Teratogenic Effect of Imatinib Mesylate: A Very Rare Case Report
OBJECTIVE: To report a case of teratogenic effect of imatinib mesylate (IM) in a newborn, whose mother was suffering from chronic myelogenous leukemia and was treated with IM for 4 years, including during her pregnancy. CASE PRESENTATION AND INTERVENTION: The newborn was diagnosed with microtia of t...
Uloženo v:
| Vydáno v: | Med Princ Pract |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5588294/ https://ncbi.nlm.nih.gov/pubmed/25896670 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000381806 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|